China: NMPA's Announcement on Issuing 6 Guidelines regarding the Guidance on Nomenclature of Generic Names for Active Surgical Instruments and Others (No. 26 of 2022) – July 2022

• 2022-07-26 10:56:21

China's National Medical Products Administration (NMPA) has issued guidance on nomenclature of generic name for 6 subcategories.

了解更多

MALAYSIA: MDA Now Allows Multiple Authorised Representatives for A Brand Name – October, 2021

• 2021-10-27 07:06:19

Effective from June 17, 2021, MDA now allows multiple authorized representatives for each medical device (brand name) placed in the market. On the other hand, they will restrict to requiring individual establishment licenses to carry out role/activity of various economic operators, as prescribed in the Medical Device Regulations 2012.

MDA Circular Letter No. 1/2014 contains two components, which are the establishment that acts as an authorized representative (AR) and the establishment that carries out various activities.

了解更多